BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15044940)

  • 1. Unilateral drug-induced ocular pseudopemphigoid.
    Gibran SK
    Eye (Lond); 2004 Dec; 18(12):1270. PubMed ID: 15044940
    [No Abstract]   [Full Text] [Related]  

  • 2. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
    Baudouin C
    Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular pseudopemphigoid after topical drug administration].
    Anders N; Wollensak J
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):61-4. PubMed ID: 7967407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of preservatives in anti-glaucoma agents on the ocular surface].
    Potop V
    Oftalmologia; 2009; 53(2):92-6. PubMed ID: 19697847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced cicatrising granulomatous conjunctivitis.
    Kahana A; Marcet MM; Albert DM; Thliveris AT
    Br J Ophthalmol; 2007 May; 91(5):691-2. PubMed ID: 17446509
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced ocular cicatricial pemphigoid: a series of clinico-pathological reports.
    Butt Z; Kaufman D; McNab A; McKelvie P
    Eye (Lond); 1998; 12 ( Pt 2)():285-90. PubMed ID: 9683956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiglaucoma drops--with or without preservatives].
    Zemba M
    Oftalmologia; 2009; 53(2):26-30. PubMed ID: 19697836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular toxicity of benzalkonium].
    Chibret H
    Ann Pharm Fr; 2011 Mar; 69(2):108-15. PubMed ID: 21440103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservatives in eyedrops: the good, the bad and the ugly.
    Baudouin C; Labbé A; Liang H; Pauly A; Brignole-Baudouin F
    Prog Retin Eye Res; 2010 Jul; 29(4):312-34. PubMed ID: 20302969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The deleterious effect of certain surface active agents on the ocular surface].
    Ravet O
    Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Managing treatment side effects: the respective roles of the active ingredient and the preservative].
    Aptel F; Denis P; Baudouin C
    J Fr Ophtalmol; 2011 Jun; 34(6):409-12. PubMed ID: 21511364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of IOP reduction with travoprost BAK-free solution.
    Gross RL; Peace JH; Smith SE; Walters TR; Dubiner HB; Weiss MJ; Ochsner KI
    J Glaucoma; 2008; 17(3):217-22. PubMed ID: 18414108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy.
    Lewis RA; Katz GJ; Weiss MJ; Landry TA; Dickerson JE; James JE; Hua SY; Sullivan EK; Montgomery DB; Wells DT; Bergamini MV;
    J Glaucoma; 2007 Jan; 16(1):98-103. PubMed ID: 17224758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular surface disease in patients with ocular hypertension and glaucoma.
    Stewart WC; Stewart JA; Nelson LA
    Curr Eye Res; 2011 May; 36(5):391-8. PubMed ID: 21501071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis with use of eye-drops containing benzalkonium chloride preservative.
    Anderson D; Faltay B; Haller NA
    Clin Exp Optom; 2009 Sep; 92(5):444-6. PubMed ID: 19549228
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced pemphigoid. A spectrum of diseases.
    Fiore PM; Jacobs IH; Goldberg DB
    Arch Ophthalmol; 1987 Dec; 105(12):1660-3. PubMed ID: 3318771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudopemphigoid Induced by Topical Glaucoma Medications].
    Geerling G; Roth M
    Klin Monbl Augenheilkd; 2019 Jun; 236(6):762-766. PubMed ID: 31195414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxicity research status of benzalkonium chloride on ocular surface].
    Huang C; Chen W; Chen Y; Liu Z
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):303-6. PubMed ID: 24931157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of common ophthalmic preservatives on ocular health.
    Noecker R
    Adv Ther; 2001; 18(5):205-15. PubMed ID: 11783457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.